148 related articles for article (PubMed ID: 34861349)
1. Synthesis of unnatural morphinan compounds to induce itch-like behaviors in mice: Towards the development of MRGPRX2 selective ligands.
Iio K; Kutsumura N; Nagumo Y; Saitoh T; Tokuda A; Hashimoto K; Yamamoto N; Kise R; Inoue A; Mizoguchi H; Nagase H
Bioorg Med Chem Lett; 2022 Jan; 56():128485. PubMed ID: 34861349
[TBL] [Abstract][Full Text] [Related]
2. Osthole, a Natural Plant Derivative Inhibits MRGPRX2 Induced Mast Cell Responses.
Callahan BN; Kammala AK; Syed M; Yang C; Occhiuto CJ; Nellutla R; Chumanevich AP; Oskeritzian CA; Das R; Subramanian H
Front Immunol; 2020; 11():703. PubMed ID: 32391014
[TBL] [Abstract][Full Text] [Related]
3. Thimerosal induces skin pseudo-allergic reaction via Mas-related G-protein coupled receptor B2.
Peng B; Che D; Hao Y; Zheng Y; Liu R; Qian Y; Cao J; Wang J; Zhang Y; He L; Geng S
J Dermatol Sci; 2019 Sep; 95(3):99-106. PubMed ID: 31558225
[TBL] [Abstract][Full Text] [Related]
4. MRGPRX2 sensing of cationic compounds-A bridge between nociception and skin diseases?
Corbière A; Loste A; Gaudenzio N
Exp Dermatol; 2021 Feb; 30(2):193-200. PubMed ID: 33107136
[TBL] [Abstract][Full Text] [Related]
5. A novel MRGPRX2-targeting antagonistic DNA aptamer inhibits histamine release and prevents mast cell-mediated anaphylaxis.
Suzuki Y; Liu S; Ogasawara T; Sawasaki T; Takasaki Y; Yorozuya T; Mogi M
Eur J Pharmacol; 2020 Jul; 878():173104. PubMed ID: 32320700
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of Compound 48/80-Mediated Itch and LL-37-Induced Inflammation by a Single-Stranded Oligonucleotide.
Dondalska A; Rönnberg E; Ma H; Pålsson SA; Magnusdottir E; Gao T; Adam L; Lerner EA; Nilsson G; Lagerström M; Spetz AL
Front Immunol; 2020; 11():559589. PubMed ID: 33101278
[TBL] [Abstract][Full Text] [Related]
7. A group of cationic amphiphilic drugs activates MRGPRX2 and induces scratching behavior in mice.
Wolf K; Kühn H; Boehm F; Gebhardt L; Glaudo M; Agelopoulos K; Ständer S; Ectors P; Zahn D; Riedel YK; Thimm D; Müller CE; Kretschmann S; Kremer AN; Chien D; Limjunyawong N; Peng Q; Dong X; Kolkhir P; Scheffel J; Søgaard ML; Weigmann B; Neurath MF; Hawro T; Metz M; Fischer MJM; Kremer AE
J Allergy Clin Immunol; 2021 Aug; 148(2):506-522.e8. PubMed ID: 33617860
[TBL] [Abstract][Full Text] [Related]
8. New insight into prurigo nodularis: Proadrenomedullin N-terminal 20 peptide mediates mouse mast cell activation via Mrgprb2.
Shao Y; Xiao Z; Jin Y; Zhu Y; Shen Y; Jin T; Tang H; Wang D
Skin Res Technol; 2024 Feb; 30(2):e13588. PubMed ID: 38284237
[TBL] [Abstract][Full Text] [Related]
9. Activation of Mast-Cell-Expressed Mas-Related G-Protein-Coupled Receptors Drives Non-histaminergic Itch.
Meixiong J; Anderson M; Limjunyawong N; Sabbagh MF; Hu E; Mack MR; Oetjen LK; Wang F; Kim BS; Dong X
Immunity; 2019 May; 50(5):1163-1171.e5. PubMed ID: 31027996
[TBL] [Abstract][Full Text] [Related]
10. All-trans-retinoic acid activated mast cells via Mas-related G-protein-coupled receptor-X2 in retinoid dermatitis.
Zheng Y; Che D; Peng B; Hao Y; Zhang X; He L; Geng S
Contact Dermatitis; 2019 Sep; 81(3):184-193. PubMed ID: 31006867
[TBL] [Abstract][Full Text] [Related]
11. Lactic acid suppresses MRGPRX2 mediated mast cell responses.
Syed M; Kammala AK; Callahan B; Oskeritzian CA; Subramanian H
Cell Immunol; 2021 Oct; 368():104422. PubMed ID: 34399172
[TBL] [Abstract][Full Text] [Related]
12. Structure, function and pharmacology of human itch GPCRs.
Cao C; Kang HJ; Singh I; Chen H; Zhang C; Ye W; Hayes BW; Liu J; Gumpper RH; Bender BJ; Slocum ST; Krumm BE; Lansu K; McCorvy JD; Kroeze WK; English JG; DiBerto JF; Olsen RHJ; Huang XP; Zhang S; Liu Y; Kim K; Karpiak J; Jan LY; Abraham SN; Jin J; Shoichet BK; Fay JF; Roth BL
Nature; 2021 Dec; 600(7887):170-175. PubMed ID: 34789874
[TBL] [Abstract][Full Text] [Related]
13. GRK2 differentially regulates FcεRI and MRGPRB2-mediated responses in mast cells.
Thapaliya M; Ali H
Front Immunol; 2023; 14():1155777. PubMed ID: 37063868
[TBL] [Abstract][Full Text] [Related]
14. Mast Cells Initiate Type 2 Inflammation through Tryptase Released by MRGPRX2/MRGPRB2 Activation in Atopic Dermatitis.
Jia T; Che D; Zheng Y; Zhang H; Li Y; Zhou T; Peng B; Du X; Zhu L; An J; Geng S
J Invest Dermatol; 2024 Jan; 144(1):53-62.e2. PubMed ID: 37482287
[TBL] [Abstract][Full Text] [Related]
15. MRGPRX2 signals its importance in cutaneous mast cell biology: Does MRGPRX2 connect mast cells and atopic dermatitis?
Wang Z; Babina M
Exp Dermatol; 2020 Nov; 29(11):1104-1111. PubMed ID: 32866307
[TBL] [Abstract][Full Text] [Related]
16. In silico design of novel probes for the atypical opioid receptor MRGPRX2.
Lansu K; Karpiak J; Liu J; Huang XP; McCorvy JD; Kroeze WK; Che T; Nagase H; Carroll FI; Jin J; Shoichet BK; Roth BL
Nat Chem Biol; 2017 May; 13(5):529-536. PubMed ID: 28288109
[TBL] [Abstract][Full Text] [Related]
17. MRGPRX2 antagonist GE1111 attenuated DNFB-induced atopic dermatitis in mice by reducing inflammatory cytokines and restoring skin integrity.
Wong TK; Choi YG; Li PH; Chow BKC; Kumar M
Front Immunol; 2024; 15():1406438. PubMed ID: 38817611
[TBL] [Abstract][Full Text] [Related]
18. Substance P analogs devoid of key residues fail to activate human mast cells
Raj S; Hlushak S; Arizmendi N; Kovalenko A; Kulka M
Front Immunol; 2023; 14():1155740. PubMed ID: 37228611
[TBL] [Abstract][Full Text] [Related]
19. The Multifaceted Mas-Related G Protein-Coupled Receptor Member X2 in Allergic Diseases and Beyond.
Quan PL; Sabaté-Brescó M; Guo Y; Martín M; Gastaminza G
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922606
[TBL] [Abstract][Full Text] [Related]
20. MRGPRX2 is essential for sinomenine hydrochloride induced anaphylactoid reactions.
Liu R; Che D; Zhao T; Pundir P; Cao J; Lv Y; Wang J; Ma P; Fu J; Wang N; Wang X; Zhang T; Dong X; He L
Biochem Pharmacol; 2017 Dec; 146():214-223. PubMed ID: 28987593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
